Memantine for chronic pain… what’s the verdict?

Memantine, fibromyalgia drug, fibromyalgia pain, fibromyalgia support Memantine has been shown to have pain-relieving properties in small clinical studies but a review of the evidence in the European Journal of Pain is less promising.

“Among the 11 studies looking at chronic pain treatment, the difference in end pain score with memantine was not significant,” the authors explain. “In two surgical studies using memantine for pain prevention, memantine decreased pain intensity. Dizziness was significantly more common with memantine.

“The current evidence regarding the use of memantine for chronic pain is limited and uncertain. Despite its potential, pain relief achieved in clinical studies is small and is associated with an increase in dizziness.”

So despite a sound rationale, the benefit of using memantine for chronic pain is unclear. It certainly has the potential to decrease pain but it can also increase common adverse effects.

The authors conclude:

“No clear recommendations can be made about [memantine’s] routine clinical use until larger and more definitive studies are conducted.”

Click here for the original research.

Arthritis Digest Magazine was selected by Feedspot as one of the Top 5 Arthritis Blogs on the internet in 2018.

For more in-depth features, interviews and information, subscribe to Arthritis Digest magazine, a popular title that’s published six times a year. Click here for the digital version or tel 0845 643 8470 to order your had copy. You’ll know what your doctor is talking about, what new drugs are in the pipeline and be up to date on helpful products.